Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-09-26 | 2026-06-27 | 2026-03-28 | 2025-12-31 | 2025-09-27 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 1.19%12,137.00 | 11,994.00 | 11,005.00 | 12,215.00 | 11,122.00 |
0.51%2,321.00 | 2,333.00 | 2,181.00 | - | - | |
| Selling, General, and Administrative | 0.51%2,321.00 | 2,333.00 | 2,181.00 | - | - |
| Research and Development | 4.40%348.00 | 364.00 | 336.00 | - | - |
| Costs And Expenses | 0.33%9,874.00 | 9,907.00 | 9,142.00 | 9,960.00 | 9,182.00 |
| Operating Income/Loss | 8.43%2,263.00 | 2,087.00 | 1,863.00 | 2,255.00 | 1,941.00 |
| Income/Loss From Equity Method Investments | 40.00%-9.00 | -15.00 | -8.00 | -32.00 | 2.00 |
| Income/Loss From Continuing Operations Before Tax | 8.52%2,088.00 | 1,924.00 | 1,734.00 | 2,153.00 | 1,826.00 |
| Income Tax Expense/Benefit, Deferred | 0.96%-210.00 | -208.00 | -258.00 | 89.00 | -127.00 |
| Income Tax Expense/Benefit | 110.78%352.00 | 167.00 | 70.00 | 153.00 | 207.00 |
0.80%1,727.00 | 1,741.00 | 1,656.00 | 1,970.00 | 1,621.00 | |
| Attributable To Parent | 0.86%1,721.00 | 1,736.00 | 1,651.00 | 1,964.00 | 1,616.00 |
20.00%6.00 | 5.00 | 5.00 | 6.00 | 5.00 | |
| Redeemable Noncontrolling Interest | 25.00%5.00 | 4.00 | 4.00 | 30.00 | -5.00 |
| Basic Average Shares | 0.27%370.00 | 371.00 | 372.00 | -1.00 | 378.00 |
| Diluted Average Shares | 371.00 | 371.00 | 373.00 | - | 378.00 |
| Basic Earnings Per Share | 0.64%4.65 | 4.68 | 4.44 | 5.22 | 4.28 |
| Diluted Earnings Per Share | 0.85%4.64 | 4.68 | 4.43 | 5.21 | 4.27 |
| Common Stock Dividends | 0.47 | 0.47 | 0.47 | 0.43 | 0.43 |